Neurofeedback for Obesity
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you do not use anti-obesity medications. If you are taking these, you would need to stop before participating.
What data supports the effectiveness of the treatment Craving Network Neurofeedback for obesity?
Research shows that neurofeedback training can help people with obesity improve self-control over food choices by increasing the connection between brain areas involved in decision-making and reward. This suggests that neurofeedback might be useful in managing weight by enhancing control over cravings.12345
Is neurofeedback safe for humans?
Research on neurofeedback, including studies on eating behaviors and obesity, suggests it is generally safe for humans. Participants in these studies did not report significant adverse effects, indicating that neurofeedback may be a safe tool for modifying brain activity related to food cravings and eating behaviors.12367
How does Craving Network Neurofeedback treatment for obesity differ from other treatments?
Craving Network Neurofeedback is unique because it uses real-time brain activity feedback to help individuals regulate their brain responses to food stimuli, enhancing self-control over food cravings. Unlike traditional weight loss methods, this treatment focuses on increasing connectivity between specific brain areas involved in decision-making and reward processing, potentially leading to healthier food choices.12345
What is the purpose of this trial?
This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.
Research Team
Kathleen A Garrison, PhD
Principal Investigator
Yale University
Eligibility Criteria
This trial is for adults aged 18 to 60 who are overweight or obese, with a body mass index (BMI) over 25 and experience strong food cravings as indicated by scoring more than 2.37 on the Food Craving Inventory.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Neurofeedback Treatment
Participants undergo three imaging (fMRI) sessions of experimental or sham neurofeedback
Follow-up
Participants are monitored for changes in craving network strength and eating behavior
Treatment Details
Interventions
- Craving Network Neurofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator